Jack Wei Chieh TanDerek P. ChewDavid BriegerJohn EikelboomGilles MontalescotJunya AkoByeong Keuk KimDavid K.L. QuekSarah J. AitkenClara K. ChowSok ChourHung Fat TseUpendra KaulIsman FirdausTakashi KuboBoon Wah LiewTze Tec ChongKenny Y.K. SinHung I. YehWacin BuddhariNarathip ChunhamaneewatFaisal HasanKeith A.A. FoxQuang Ngoc NguyenSidney T.H. LoSiriraj HospitalThe College of Medicine and Public HealthCleveland Clinic Abu DhabiHopital CalmetteHanoi Medical UniversityUniversitas IndonesiaBatra Hospital IndiaMcMaster UniversityMackay Memorial Hospital TaiwanThe University of EdinburghThe University of SydneyWakayama Medical UniversityKing Chulalongkorn Memorial HospitalSingapore General HospitalYonsei UniversityHôpital Universitaire Pitié SalpêtrièreChangi General HospitalPantai Holdings Sdn BhdThe University of Hong KongKitasato UniversityWestmead HospitalNational Heart Centre, SingaporeSorbonne UniversiteLiverpool HospitalACTION Study GroupSengkang General Hospital2022-08-042022-08-042021-01-01European Cardiology Review. Vol.16, (2021)17583764175837562-s2.0-85109820982https://repository.li.mahidol.ac.th/handle/123456789/78690The unique characteristics of patients with chronic coronary syndrome (CCS) in the Asia-Pacific region, heterogeneous approaches because of differences in accesses and resources and low number of patients from the Asia-Pacific region in pivotal studies, mean that international guidelines cannot be routinely applied to these populations. The Asian Pacific Society of Cardiology developed these consensus recommendations to summarise current evidence on the management of CCS and provide recommendations to assist clinicians treat patients from the region. The consensus recommendations were developed by an expert consensus panel who reviewed and appraised the available literature, with focus on data from patients in Asia-Pacific. Consensus statements were developed then put to an online vote. The resulting recommendations provide guidance on the assessment and management of bleeding and ischaemic risks in Asian CCS patients. Furthermore, the selection of long-term antithrombotic therapy is discussed, including the role of single antiplatelet therapy, dual antiplatelet therapy and dual pathway inhibition therapy.Mahidol UniversityMedicineArticleSCOPUS10.15420/ECR.2020.45